Lanean...
Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition
Resistance to EGFR kinase inhibitors appears to be invariable in the treatment of non-small cell lung cancer. Several mechanisms have been described. Here, we report the first case of histologic transformation of EGFR mutant lung adenocarcinoma without prior exposure to EGFR inhibition.
Gorde:
| Argitaratua izan da: | Lung Cancer |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330183/ https://ncbi.nlm.nih.gov/pubmed/28236979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2017.01.005 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|